Characteristic | Episcleritis, n = 23 | Scleritis, n = 33 | PUK, n = 21 | Uveitis, n = 14 | p |
---|---|---|---|---|---|
Bilateral involvement | 7 (30) | 11 (33) | 7 (33) | 2 (14) | 0.59 |
Eye redness, N/A 13 | 21 (100) | 29 (91) | 11 (65) | 8 (100) | 0.004 |
Eye pain, N/A 8 | 7 (33) | 19 (63) | 9 (45) | 8 (67) | 0.12 |
Headache, N/A 11 | 1 (5) | 7 (23) | 2 (11) | 0 (0) | 0.12 |
Blurred vision, N/A 12 | 2 (10) | 8 (27) | 5 (28) | 4 (36) | 0.34 |
Vision loss, N/A 11 | 1 (5) | 5 (17) | 6 (32) | 1 (9) | 0.14 |
Floaters/flashes of light, N/A 12 | 1 (5) | 1 (3) | 1 (5) | 1 (9) | 0.91 |
Dry eye/foreign body sensation, N/A 14 | 8 (42) | 5 (19) | 11 (55) | 1 (9) | 0.014 |
Eye/orbital swelling, N/A 14 | 2 (10) | 4 (15) | 3 (17) | 1 (9) | 0.90 |
ESR, mm/h, N/A 49 | 16.0 (10.0–22.0) | 14.5 (10.0–38.0) | 20.0 (10.0–27.0) | 13.0 (5.0–31.0) | 0.82 |
CRP, mg/l, N/A 63 | 6.0 (3.0–11.6) | 11.9 (3.5–54.3) | 17.5 (5.1–35.5) | 6.8 (2.9–12.3) | 0.67 |
WBC, ×109/l, N/A 37 | 9.0 (7.0–9.5) | 7.9 (7.4–11.8) | 8.9 (6.8–10.1) | 8.5 (5.4–9.0) | 0.59 |
Hb, g/dl, N/A 37 | 13.1 (12.3–13.8) | 13.1 (11.9–14.2) | 14.1 (11.6–15.4) | 13.3 (12.5–14.2) | 0.45 |
Plt, ×109/l, N/A 37 | 276 (244–322) | 261 (230–339) | 256 (187–377) | 242 (226–322) | 0.84 |
Creatinine, mg/dl, N/A 52 | 0.9 (0.7–1.0) | 1.0 (0.7–1.2) | 1.0 (0.8–1.2) | 0.8 (0.8–0.9) | 0.45 |
Cataracts, N/A 7 | 5 (26) | 10 (33) | 8 (38) | 8 (57) | 0.31 |
Data in bold face are statistically significant. RA: rheumatoid arthritis; PUK: peripheral ulcerative keratitis; ESR: erythrocyte sedimentation rate (normal values < 22 mm/h in male and < 29 mm/h in female); CRP: C-reactive protein (normal values < 8 mg/l); WBC: white blood cells (normal values < 10.5 × 109/l); Hb: hemoglobin (normal values > 13.5 g/dl in male, > 12 g/dl in female); Plt: platelets (normal values > 450 × 109/l); N/A: not available.